NASDAQ:SRPT

Sarepta Therapeutics Stock Predictions

etoro logo Buy SRPT
*Your capital is at risk
$16.24
-0.0100 (-0.0615%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

SRPT Prediction Chart

SRPT Predictions History

Latest community submissions for SRPT.
Predictor Target Session Target Price Result Direction Accuracy Score
nwright0808 nwright0808 Merchant
Nov 3, 2025 $30.18 +25.70% $24.46 V 76.61% 1
Oct 29, 2025 $23.70 -2.16% $23.45 V 98.94% 2
Oct 29, 2025 $23.89 -1.35% $23.45 V 98.11% 1
nwright0808 nwright0808 Merchant
Oct 29, 2025 $35.34 +45.91% $23.45 X 49.30% 0
Oct 24, 2025 $22.41 +2.38% $22.81 V 98.25% 1
Oct 24, 2025 $22.21 +1.48% $22.81 V 97.39% 1
nwright0808 nwright0808 Merchant
Oct 24, 2025 $28.82 +28.26% $22.81 V 73.65% 1
Oct 20, 2025 $21.97 -2.40% $23.05 X 95.32% 0
Oct 20, 2025 $22.17 -1.50% $23.05 X 96.19% 0
nwright0808 nwright0808 Merchant
Oct 20, 2025 $35.59 +58.11% $23.05 V 45.60% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for SRPT with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT SAREPTA THERAPEUTICS
Sarepta Therapeutics
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; and VYONDYS 53 for the treatment of ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE